Generate Biomedicines, Inc. (GENB)

20.90 +3.18 (+17.95%) USD  |  NASDAQ  |  Aug 25, 11:13
More

Generate Biomedicines Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for GENB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2026. Start Trial.
Date Value
August 17, 2026 --
August 07, 2026 --
August 06, 2026 --
May 14, 2026 --
May 13, 2026 --
Date Value
May 08, 2026 --
May 07, 2026 --
April 13, 2026 --
April 02, 2026 --
March 24, 2026 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Twist Bioscience Corp. Upgrade
Prime Medicine, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade